Pfizer Q2 Results FY27: PAT Jumps 65.72% to Rs 313.25 Cr, Revenue Rs 726.86 Cr
- November 4, 2026
- Posted by: Harsh Piplani
- Category: Results
Quick Answer
Pfizer Q2 Results FY27 were declared on 3 November 2026 on a standalone basis. Revenue came in at Rs 726.86 Cr, a YoY growth of 13.16 percent from Rs 642.34 Cr. Net profit rose 65.72 percent to Rs 313.25 Cr from Rs 189.02 Cr. These quarterly results cover July to September 2026.
Pfizer Ltd (PFIZER) Q2 Results FY27 announced on 3 November 2026, covering the company’s financial performance for the July to September quarter. The company reported revenue of Rs 726.86 Cr and PAT of Rs 313.25 Cr. Pfizer Q2 Results FY27 set out the full picture for the quarter. The results date of 3 November 2026 and the standalone results basis frame every figure below.
This Pfizer Q2 Results results analysis covers the financial highlights, the business factors, the outlook and the risks, and it starts with the Financial Highlights table. Univest readers can use the Univest Screener to compare these figures with other listed companies.
Click Here – Get Free Investment Predictions
Pfizer Q2 Results FY27: Financial Highlights
| Metric | Q2 FY27 (Sep 26) | Q2 FY26 (Sep 25) | YoY Change |
|---|---|---|---|
| Revenue | Rs 726.86 Cr | Rs 642.34 Cr | +13.16% YoY |
| Operating Profit | Rs 261.2 Cr | Rs 229.93 Cr | +13.6% YoY |
| Net Profit (PAT) | Rs 313.25 Cr | Rs 189.02 Cr | +65.72% YoY |
Source: company filing for Pfizer Q2 Results FY27, 3 November 2026. Figures in Rs Crore, Standalone basis.
Key Takeaways from Pfizer Q2 Results: What Stands Out
- Revenue of Rs 726.86 Cr rose 13.16 percent from Rs 642.34 Cr in the same quarter of last year.
- Net profit of Rs 313.25 Cr compares with Rs 189.02 Cr a year ago, a YoY growth of 65.72 percent.
- Operating Profit of Rs 261.20 Cr rose 13.60 percent from Rs 229.93 Cr in the same quarter of last year.
- Net profit margin of 43.1 percent compares with 29.4 percent in the comparison quarter, as Pfizer Q2 Results FY27 show.
- Return on equity of 17.16 percent in FY26 sits alongside flagged risks, and the performance analysis now takes up these numbers.
Pfizer Q2 Results FY27: Performance Analysis
Pfizer reported standalone revenue of Rs 726.86 Cr, against Rs 642.34 Cr a year earlier, while net profit moved from Rs 189.02 Cr to Rs 313.25 Cr. On a YoY basis revenue rose 13.16 percent and net profit rose 65.72 percent. Revenue, Operating Profit and net profit each moved as the Financial Highlights table shows, and every figure there matches the numbers quoted in this section.
Operating Profit rose 13.60 percent to Rs 261.20 Cr from Rs 229.93 Cr. In Pfizer Q2 Results FY27, net profit grew faster than revenue, which moved the net profit margin from 29.4 percent to 43.1 percent. The Operating Profit line and the net profit line are best read together, since each is reported as supplied in the filing, and this results analysis uses only those supplied figures.
The Pfizer Q2 Results data confirms what changed in the quarterly results but does not establish the specific cause, so the next step is to read the disclosed drivers. Investors can track later disclosures to see how the YoY growth builds across FY27, which is where the results analysis turns to the business factors.
Check the Univest Screener for live results data
Key Business Factors This Quarter
Revenue Growth – The results analysis points to revenue growth of 13.2 percent year on year to Rs 726.86 Cr in the latest quarter, and it is the first factor listed for Pfizer Q2 Results FY27.
Net Profit Growth – Net profit rose 65.7 percent year on year to Rs 313.25 Cr, and the quarterly results show it moving ahead of revenue growth, which is why the profit line stands out in this quarter’s disclosures.
Margin and Returns – Net profit margin improved to 43.1 percent from 29.4 percent in the comparison quarter, and return on equity was 17.16 percent in FY26, as supplied for this standalone filing.
FY27 Outlook After Pfizer Q2 Results
No explicit management guidance is supplied with these results, so the FY27 view rests on the numbers already reported. A quarter with revenue of Rs 726.86 Cr and net profit of Rs 313.25 Cr is one input into the full year, and the other quarters will complete it. Readers can follow later quarters through the Univest app, which lists results as companies declare them.
Full-year FY27 results will depend on subsequent quarters and on disclosed sector conditions. The Pfizer Q2 Results FY27 results analysis suggests readers watch how net profit moves against the range seen over the last five quarters, which is where the outlook hands over to the risks.
Key Risks to Watch After Pfizer Q2 Results FY27
Volatile Quarterly Net Profit
Quarterly net profit has been volatile, ranging from Rs 141.84 Cr to Rs 313.25 Cr over the last 5 quarters. Investors tracking Pfizer Q2 Results FY27 can see this quarter sits at the top of that range.
Lower Return on Equity
Return on equity declined to 17.16 percent in FY26 from 19.65 percent in FY25. The YoY growth in this quarter is a separate measure, and later disclosures will show how the full-year return develops.
Lower Return on Capital Employed
Return on capital employed declined to 23.39 percent in FY26 from 26.21 percent in FY25. This is a comparison between two annual figures, and later quarters will show whether the decline continues.
Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.
Conclusion
Pfizer Q2 Results FY27 show standalone revenue of Rs 726.86 Cr and net profit of Rs 313.25 Cr, with the quarterly results marking a YoY change of 13.16 percent in revenue. The standalone results also list return and volatility risks. This Pfizer Q2 Results summary is not advice, and investors should consult a SEBI-registered advisor before acting.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice. Research Analyst: Uniresearch Global Pvt. Ltd., SEBI Registration No. INH000013776.
Frequently Asked Questions on Pfizer Q2 Results FY27
What are Pfizer Q2 Results FY27?
Ans. Pfizer Q2 Results FY27 are the standalone quarterly results for July to September 2026, with revenue of Rs 726.86 Cr and net profit of Rs 313.25 Cr, so the Financial Highlights section carries the full comparison.
What is the results date for Pfizer Q2 Results FY27?
Ans. Pfizer Q2 Results FY27 were declared on 3 November 2026, which is the results date for the July to September 2026 quarter, and the Quick Answer box above states the same date for reference.
What revenue was reported in Pfizer Q2 Results FY27?
Ans. Pfizer reported revenue of Rs 726.86 Cr, compared with Rs 642.34 Cr a year earlier, which means revenue stands as the headline line in the Performance Analysis section.
What net profit was reported in Pfizer Q2 Results FY27?
Ans. Pfizer reported net profit of Rs 313.25 Cr in the quarter, compared with Rs 189.02 Cr a year earlier, so the Key Takeaways section treats it as a central figure.
How much YoY growth did revenue show in Pfizer Q2 Results FY27?
Ans. Revenue showed YoY growth of 13.16 percent in the quarter, alongside a net profit change of 65.72 percent, as the Performance Analysis section sets out when comparing the two lines.
Did net profit rise or fall in Pfizer Q2 Results?
Ans. Pfizer net profit rose from Rs 189.02 Cr to Rs 313.25 Cr, a change of 65.72 percent, which means the Key Takeaways section lists it among the main profit lines.
What was the Operating Profit in Pfizer Q2 Results FY27?
Ans. Operating Profit stood at Rs 261.20 Cr against Rs 229.93 Cr a year earlier, a change of 13.60 percent, as the Financial Highlights table shows alongside revenue and net profit.
Are Pfizer Q2 Results standalone results?
Ans. The figures are standalone results, so they follow the standalone basis stated in the filing, while the Quick Answer box and the Conclusion both name this basis for the quarter.
What business factors shaped Pfizer Q2 Results FY27?
Ans. The supplied factors are revenue growth of 13.2 percent, net profit growth of 65.7 percent and a net profit margin of 43.1 percent, as the Key Business Factors section explains.
What are the key risks after Pfizer Q2 Results FY27?
Ans. The risks listed are volatile quarterly net profit, a lower return on equity of 17.16 percent in FY26 and a lower return on capital employed of 23.39 percent, as the Key Risks section covers.
What is the outlook after Pfizer Q2 Results?
Ans. The FY27 outlook depends on the coming quarters, since full-year results will be built from them, while the FY27 Outlook section explains what the supplied figures can and cannot show.
Where can I find the complete Pfizer Q2 Results FY27 data?
Ans. The Financial Highlights table in this article lists revenue, Operating Profit and net profit with YoY changes, while the Univest Screener lets readers compare these figures with other listed companies.
